Nutr Res Pract.  2016 Feb;10(1):67-73. 10.4162/nrp.2016.10.1.67.

Association between dietary flavanones intake and lipid profiles according to the presence of metabolic syndrome in Korean women with type 2 diabetes mellitus

Affiliations
  • 1Department of Nutritional Science and Food Management, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Korea. nschang@ewha.ac.kr
  • 2Huh's Diabetes Clinic & the 21C Diabetes and Vascular Research Institute, Seoul 04101, Korea.

Abstract

BACKGROUND/OBJECTIVES
This study was aimed at examining the association between dietary flavanones intake and lipid profiles according to the presence of metabolic syndrome (MetS) in Korean women with type 2 diabetes mellitus (T2DM).
SUBJECTS/METHODS
A cross-sectional analysis was performed among 502 female T2DM patients (non-MetS group; n = 129, MetS group; n = 373) who were recruited from the Huh's Diabetes Clinic in Seoul, Korea between 2005 and 2011. The dietary intake was assessed by a validated semi-quantitative food frequency questionnaire (FFQ) and the data was analyzed using the Computer Aided Nutritional Analysis program (CAN-Pro) version 4.0 software. The intake of flavanones was estimated on the basis of the flavonoid database.
RESULTS
In the multiple linear regression analysis after adjustment for confounding factors, daily flavanones intake was negatively associated with CVD risk factors such as total cholesterol, LDL-cholesterol, and apoB and apoB/apoA1 ratio only in the MetS group but not in the non-MetS group. Multiple logistic regression analysis revealed that the odds ratio for a higher apoB/apoA1 ratio above the median (> or = 0.74) was significantly low in the 4th quartile compared to that in the 1st quartile of dietary flavanones intake [OR: 0.477, 95% CI: 0.255-0.894, P for trend = 0.0377] in the MetS group.
CONCLUSIONS
Dietary flavanones intake was inversely associated with the apoB/apoA1 ratio, suggesting a potential protective effect of flavanones against CVD in T2DM women with MetS.

Keyword

Apolipoprotein; flavanones; metabolic syndrome; T2DM

MeSH Terms

Apolipoproteins
Apolipoproteins B
Cholesterol
Cross-Sectional Studies
Diabetes Mellitus, Type 2*
Female
Flavanones*
Humans
Korea
Linear Models
Logistic Models
Odds Ratio
Risk Factors
Seoul
Apolipoproteins
Apolipoproteins B
Cholesterol
Flavanones

Cited by  1 articles

The Association between Food Group Consumption Patterns and Early Metabolic Syndrome Risk in Non-Diabetic Healthy People
Rimkyo Yeo, So Ra Yoon, Oh Yoen Kim
Clin Nutr Res. 2017;6(3):172-182.    doi: 10.7762/cnr.2017.6.3.172.


Reference

1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103:137–149.
Article
2. Ministry of Health and Welfare. Korea Centers for Disease Control and Prevention. Korea Health Statistics 2013: Korea National Health and Nutrition Examination Survey (KNHANES VI-1). Cheongju: Korea Centers for Disease Control and Prevention;2014.
3. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001; 44:Suppl 2. S14–S21.
Article
4. Aguilar-Salinas CA, Rojas R, Gmez-Prez FJ, Mehta R, Franco A, Olaiz G, Rull JA. The metabolic syndrome: a concept hard to define. Arch Med Res. 2005; 36:223–231.
Article
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. American Heart Association. National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735–2752.
6. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2008; 18:283–290.
Article
7. Ros E. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr. 2009; 89:1649S–1656S.
Article
8. He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet. 2006; 367:320–326.
Article
9. Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a metaanalysis of cohort studies. J Nutr. 2006; 136:2588–2593.
Article
10. Katz DL, Davidhi A, Ma Y, Kavak Y, Bifulco L, Njike VY. Effects of walnuts on endothelial function in overweight adults with visceral obesity: a randomized, controlled, crossover trial. J Am Coll Nutr. 2012; 31:415–423.
Article
11. Satija A, Hu FB. Cardiovascular benefits of dietary fiber. Curr Atheroscler Rep. 2012; 14:505–514.
Article
12. Burger KN, Beulens JW, van der Schouw YT, Sluijs I, Spijkerman AM, Sluik D, Boeing H, Kaaks R, Teucher B, Dethlefsen C, Overvad K, Tøjnneland A, Kyrø C, Barricarte A, Bendinelli B, Krogh V, Tumino R, Sacerdote C, Mattiello A, Nilsson PM, Orho-Melander M, Rolandsson O, Huerta JM, Crowe F, Allen N, Nöthlings U. Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus. PLoS One. 2012; 7:e43127.
Article
13. George TW, Waroonphan S, Niwat C, Gordon MH, Lovegrove JA. Effects of acute consumption of a fruit and vegetable purée-based drink on vasodilation and oxidative status. Br J Nutr. 2013; 109:1442–1452.
Article
14. Riccioni G, D'Orazio N, Salvatore C, Franceschelli S, Pesce M, Speranza L. Carotenoids and vitamins C and E in the prevention of cardiovascular disease. Int J Vitam Nutr Res. 2012; 82:15–26.
Article
15. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008; 88:38–50.
Article
16. Macready AL, George TW, Chong MF, Alimbetov DS, Jin Y, Vidal A, Spencer JP, Kennedy OB, Tuohy KM, Minihane AM, Gordon MH, Lovegrove JA. FLAVURS Study Group. Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease--FLAVURS: a randomized controlled trial. Am J Clin Nutr. 2014; 99:479–489.
Article
17. Reshef N, Hayari Y, Goren C, Boaz M, Madar Z, Knobler H. Antihypertensive effect of sweetie fruit in patients with stage I hypertension. Am J Hypertens. 2005; 18:1360–1363.
Article
18. Yamamoto M, Suzuki A, Hase T. Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 2008; 54:95–98.
Article
19. Jung UJ, Kim HJ, Lee JS, Lee MK, Kim HO, Park EJ, Kim HK, Jeong TS, Choi MS. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin Nutr. 2003; 22:561–568.
Article
20. Lee MK, Bok SH, Jeong TS, Moon SS, Lee SE, Park YB, Choi MS. Supplementation of naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats. Bioorg Med Chem. 2002; 10:2239–2244.
Article
21. Rizza S, Muniyappa R, Iantorno M, Kim JA, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, Quon MJ. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011; 96:E782–E792.
Article
22. Bodet C, La VD, Epifano F, Grenier D. Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models. J Periodontal Res. 2008; 43:400–407.
Article
23. Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, Sawyez CG, Whitman SC, Huff MW. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol. 2010; 30:742–748.
Article
24. Cho KW, Kim YO, Andrade JE, Burgess JR, Kim YC. Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats. Eur J Nutr. 2011; 50:81–88.
Article
25. Peterson JJ, Dwyer JT, Beecher GR, Bhagwat SA, Gebhardt SE, Haytowitz DB, Holden JM. Flavanones in oranges, tangerines (mandarins), tangors, and tangelos: a compilation and review of the data from the analytical literature. J Food Compost Anal. 2006; 19:S66–S73.
Article
26. Peterson JJ, Beecher GR, Bhagwat SA, Dwyer JT, Gebhardt SE, Haytowitz DB, Holden JM. Flavanones in grapefruit, lemons, and limes: a compilation and review of the data from the analytical literature. J Food Compost Anal. 2006; 19:S74–S80.
Article
27. Yamada T, Hayasaka S, Shibata Y, Ojima T, Saegusa T, Gotoh T, Ishikawa S, Nakamura Y, Kayaba K. Jichi Medical School Cohort Study Group. Frequency of citrus fruit intake is associated with the incidence of cardiovascular disease: The Jichi Medical School Cohort Study. J Epidemiol. 2011; 21:169–175.
Article
28. Cassidy A, Rimm EB, O'Reilly ÉJ, Logroscino G, Kay C, Chiuve SE, Rexrode KM. Dietary flavonoids and risk of stroke in women. Stroke. 2012; 43:946–951.
Article
29. Jung UJ, Lee MK, Park YB, Kang MA, Choi MS. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol. 2006; 38:1134–1145.
Article
30. Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, Markle JM, Hegele RA, Huff MW. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes. 2009; 58:2198–2210.
Article
31. Korean Diabetes Association. Committee of Clinical Practice Guideline. Treatment Guideline for Diabetes: 2013 Update. Seoul: Korean Diabetes Association;2013.
32. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499–502.
Article
33. Lauer RM, Lee J, Clarke WR. Factors affecting the relationship between childhood and adult cholesterol levels: The Muscatine Study. Pediatrics. 1988; 82:309–318.
34. Oh SY, Kim EM, Shin MH, Lee SH, Kim JE, Lee HS, Jo JS, Kim WY. Development and validation of food frequency questionnaire for adults. Proceedings of the Korean Society of Health Promotion Annual Spring Conference; 2007 May 19; Seoul. Seoul: Korean Society of Health Promotion;2007.
35. Yang YK, Kim JY, Kwon O. Development of flavonoid database for commonly consumed foods by Koreans. Korean J Nutr. 2012; 45:283–292.
Article
36. Yang YJ, Kim YJ, Yang YK, Kim JY, Kwon O. Dietary flavan-3-ols intake and metabolic syndrome risk in Korean adults. Nutr Res Pract. 2012; 6:68–77.
Article
37. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007; 85:895–909.
Article
38. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001; 358:2026–2033.
Article
39. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (The INTERHEART Study): case-control study. Lancet. 2004; 364:937–952.
Article
40. Pipe EA, Gobert CP, Capes SE, Darlington GA, Lampe JW, Duncan AM. Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes. J Nutr. 2009; 139:1700–1706.
Article
41. Kim JE, Kim WY, Lee YJ, Park JE, Choi YJ, Huh KB, Hwang JY. Associations between ApoB/ApoA-I ratios and metabolic syndrome and its components in patients with type 2 diabetes. Korean Diabetes J. 2009; 33:143–154.
Article
42. Jing F, Mao Y, Guo J, Zhang Z, Li Y, Ye Z, Ding Y, Wang J, Jin M, Chen K. The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study. Lipids Health Dis. 2014; 13:81.
Article
43. Mulero J, Bernab J, Cerd B, Garca-Viguera C, Moreno DA, Albaladejo MD, Avils F, Parra S, Abelln J, Zafrilla P. Variations on cardiovascular risk factors in metabolic syndrome after consume of a citrus-based juice. Clin Nutr. 2012; 31:372–377.
Article
44. Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J. 2006; 70:1437–1442.
Article
45. Menegotto G, Moraes Silva F, de Azevedo MJ, de Almeida JC. Lunch energy density and the metabolic syndrome in patients with type 2 diabetes mellitus. Br J Nutr. 2013; 110:1656–1663.
Article
46. Silva FM, Steemburgo T, de Mello VD, Tonding SF, Gross JL, Azevedo MJ. High dietary glycemic index and low fiber content are associated with metabolic syndrome in patients with type 2 diabetes. J Am Coll Nutr. 2011; 30:141–148.
Article
47. Steemburgo T, Dall'Alba V, Almeida JC, Zelmanovitz T, Gross JL, de Azevedo MJ. Intake of soluble fibers has a protective role for the presence of metabolic syndrome in patients with type 2 diabetes. Eur J Clin Nutr. 2009; 63:127–133.
Article
48. Yoo KB, Suh HJ, Lee M, Kim JH, Kwon JA, Park EC. Breakfast eating patterns and the metabolic syndrome: The Korea National Health and Nutrition Examination Survey (KNHANES) 2007-2009. Asia Pac J Clin Nutr. 2014; 23:128–137.
49. de Oliveira EP, McLellan KC, Vaz de Arruda Silveira L, Burini RC. Dietary factors associated with metabolic syndrome in Brazilian adults. Nutr J. 2012; 11:13.
Article
50. Freire RD, Cardoso MA, Gimeno SG, Ferreira SR. Japanese-Brazilian Diabetes Study Group. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care. 2005; 28:1779–1785.
Article
51. Oh JS, Ahn MJ, Han CJ, Kim H, Kwon O, Chung HW, Chang N. Relationship between flavonoids intake and metabolic syndrome in Korean women with polycystic ovary syndrome. J Nutr Health. 2014; 47:176–185.
Article
52. Shin JA, Lee JH, Lim SY, Ha HS, Kwon HS, Park YM, Lee WC, Kang MI, Yim HW, Yoon KH, Son HY. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig. 2013; 4:334–343.
Article
53. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006; 332:73–78.
Article
54. Yang YK. Construction of flavonoid database for the estimation of flavonoid intake in Korean [Ph. D. thesis]. Seoul: Ewha Womans University;2011.
Full Text Links
  • NRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr